ARS Pharmaceuticals Inc (NASDAQ:SPRY)
| 5.32 Delayed Data As of Dec 08 |  +0.095 / +1.82%Today’s Change | 2.55 Today|||52-Week Range 9.65 | -37.69% Year-to-Date |
Latest SPRY News | Press Releases
No recent news for ARS Pharmaceuticals Inc.
Today’s Trading
| Previous close | 5.22 |
| Today’s open | 5.19 |
| Day’s range | 5.13 - 5.38 |
| Volume | 22,373 |
| Average volume (3 months) | 1,101,082 |
| Market cap | $510.7M |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | +66.12% |
| Earnings growth (this year) | +11.88% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 258.99 |
| Price/Book | 1.83 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 21, 2024 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $1.3M |
| Annual profit (last year) | -$34.7M |
| Net profit margin | -2,635.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
